20多年来,利图西马布治疗抗中性粒细胞质抗体相关的血管炎

Mohammad Amin Habibi1, Sajjad Ahmadpour2, Javad Tafaroji3

  • 1Department of Neurosurgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

Current drug targets
|September 25, 2024
PubMed
概括

利图西马布 (RTX) 为抗中性粒细胞质抗体相关血管炎 (AAVs) 提供了一种更有效,更安全的治疗方法,减少了对葡萄糖皮质体和免疫抑制剂的需求. 需要对复发预测生物标志物的进一步研究.

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
119